Oral ferric maltol versus intravenous ferric carboxymaltose for the treatment of iron-deficiency anaemia in patients with inflammatory bowel disease: a multicentre phase 3b, open-label randomised controlled trial

Stefanie Howaldt  1     Nicholas Martinez  2     Eugeni Domenech Morral  3     Mark Sampson  4    
1 MVZ für Immunologie,Hamburg,Germany
2 Gastroenterology Research of America,San Antonio,United States
3 Hospital Germans Trias i Pujol,Badalona,Spain
4 Shield Therapeutics plc,London,United Kingdom

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing